Entropy Technologies’s Cymabay Therapeutics CBAY Stock Holding History

Entropy Technologies’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-27,116	Closed	-$640K	–	913
2023 Q4	$640K	Buy	+27,116	New	+$483K	0.12%	287

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Entropy Technologies's CBAY Position: Q1 2024 in Review

Entropy Technologies sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 27,116 shares — an estimated $640K sold.

Entropy Technologies first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $640K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Entropy Technologies reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Entropy Technologies sold 27,116 Cymabay Therapeutics shares in Q1 2024, an estimated $640K.
Entropy Technologies first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
Entropy Technologies's Cymabay Therapeutics position peaked at $640K in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Entropy Technologies's 13F filing for Q1 2024, filed 8 May 2024.